In addition, as a negative regulator of EMT and metastasis in LUAD, KLF17 regulated the Smad3-dependent pathway to enhance TGFβ1/SMAD signaling, and was a key link in anti-tumor metastasis or growth [85]. The gene discussed is KLF17; the disease is neoplasm.